Home › Trial NCT06098898
Safety and Efficacy of NK510 to Treat Gastric Cancer
- Trial IDNCT06098898
- StatusUnknown
- PhaseEarly Phase 1
- Study typeInterventional
- SponsorBase Therapeutics (Shanghai) Co., Ltd.
- Enrollment9
- Start date2023-11-01
- ConditionsGastric Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.